Clinical Trial Update: A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RO5459072 for primary Sjogren's syndrome has completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• RO5459072

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Sjogren's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-08-01